Currently out of the existing stock ratings of Ananda Ghosh, 17 are a BUY (89.47%), 2 are a HOLD (10.53%).

Ananda Ghosh

Work Performance Price Targets & Ratings Chart

Analyst Ananda Ghosh, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 50% that have a potential upside of 100.7% achieved within 155 days.

Ananda Ghosh’s has documented 35 price targets and ratings displayed on 3 stocks.

Most recent stock forecast was given on GPCR, Structure Therapeutics American Depositary Shares at 11-Jun-2026.

Wall Street Analyst Ananda Ghosh

Analyst best performing recommendations are on RNA (AVIDITY BIOSCIENCES ).
The best stock recommendation documented was for GPCR (STRUCTURE THERAPEUTICS AMERICAN DEPOSITARY SHARES) at 12/22/2025. The price target of $90 was fulfilled within 29 days with a profit of $26.75 (42.29%) receiving and performance score of 14.58.

Average potential price target upside

GPCR Structure Therapeutics American Depositary Shares IVA Inventiva Sa RNA Avidity Biosciences 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Dec-2024

$70

$20.29 (40.82%)

$100

1 months 20 days ago
(11-Jun-2026)

3/6 (50%)

$26.7 (61.66%)

229

Buy Since 19-Oct-2023

$113

$63.29 (127.32%)

5 months 4 days ago
(27-Feb-2026)

9/10 (90%)

$50.02 (79.42%)

530

Buy Since 21-May-2024

$105

$55.29 (111.23%)

$65

6 months 9 days ago
(22-Jan-2026)

1/2 (50%)

$13.13 (14.29%)

566

Buy Since 28-Feb-2023

$140

$90.29 (181.63%)

$90

6 months 11 days ago
(20-Jan-2026)

2/3 (66.67%)

$48.98 (53.81%)

190

Buy Since 23-Sep-2024

$125

$75.29 (151.46%)

$120

7 months 19 days ago
(12-Dec-2025)

0/3 (0%)

$57.94 (86.40%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Ananda Ghosh is most bullish on?

Potential upside of $20.88 has been obtained for GPCR (STRUCTURE THERAPEUTICS AMERICAN DEPOSITARY SHARES)

Which stock is Ananda Ghosh is most reserved on?

Potential downside of -$0 has been obtained for RNA (AVIDITY BIOSCIENCES )

What Year was the first public recommendation made by Ananda Ghosh?

On 2024

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?